D.E. Shaw & Co’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-636,897
| Closed | -$15M | – | 3497 |
|
|
2023
Q4 | $15M | Sell |
636,897
-161,112
| -20% | -$3.81M | 0.01% | 684 |
|
|
2023
Q3 | $11.9M | Buy |
798,009
+105,608
| +15% | +$1.57M | 0.01% | 749 |
|
|
2023
Q2 | $7.58M | Buy |
692,401
+143,357
| +26% | +$1.57M | 0.01% | 1043 |
|
|
2023
Q1 | $4.79M | Buy |
549,044
+280,849
| +105% | +$2.45M | 0.01% | 1358 |
|
|
2022
Q4 | $1.68M | Buy |
268,195
+43,582
| +19% | +$273K | ﹤0.01% | 2139 |
|
|
2022
Q3 | $786K | Sell |
224,613
-40,728
| -15% | -$143K | ﹤0.01% | 2664 |
|
|
2022
Q2 | $782K | Sell |
265,341
-44,941
| -14% | -$132K | ﹤0.01% | 2816 |
|
|
2022
Q1 | $965K | Buy |
310,282
+63,494
| +26% | +$197K | ﹤0.01% | 2897 |
|
|
2021
Q4 | $835K | Sell |
246,788
-101,910
| -29% | -$345K | ﹤0.01% | 2848 |
|
|
2021
Q3 | $1.27M | Sell |
348,698
-248,029
| -42% | -$905K | ﹤0.01% | 2352 |
|
|
2021
Q2 | $2.6M | Sell |
596,727
-359,794
| -38% | -$1.57M | ﹤0.01% | 1885 |
|
|
2021
Q1 | $4.34M | Sell |
956,521
-304,228
| -24% | -$1.38M | ﹤0.01% | 1427 |
|
|
2020
Q4 | $7.24M | Sell |
1,260,749
-423,737
| -25% | -$2.43M | 0.01% | 1114 |
|
|
2020
Q3 | $12.2M | Sell |
1,684,486
-1,700,686
| -50% | -$12.3M | 0.01% | 808 |
|
|
2020
Q2 | $11.8M | Buy |
3,385,172
+965,288
| +40% | +$3.37M | 0.01% | 802 |
|
|
2020
Q1 | $3.58M | Buy |
2,419,884
+398,332
| +20% | +$590K | 0.01% | 1226 |
|
|
2019
Q4 | $3.96M | Buy |
2,021,552
+1,329,633
| +192% | +$2.61M | ﹤0.01% | 1293 |
|
|
2019
Q3 | $3.54M | Buy |
691,919
+457,244
| +195% | +$2.34M | ﹤0.01% | 1303 |
|
|
2019
Q2 | $1.68M | Buy |
234,675
+222,471
| +1,823% | +$1.59M | ﹤0.01% | 1682 |
|
|
2019
Q1 | $162K | Buy |
12,204
+1,738
| +17% | +$23.1K | ﹤0.01% | 2403 |
|
|
2018
Q4 | $82K | Buy |
+10,466
| New | +$82K | ﹤0.01% | 2473 |
|